International Journal for Research and Investigation on Atherosclerosis and Related Diseases Official Journal of the European Atherosclerosis Society Affiliated with the International Atherosclerosis Society and the Society of Atherosclerosis Imaging and Prevention
Guide for Authors
Atherosclerosis is a fully electronic journal, all manuscripts are to be submitted via the internet.
To submit your paper online, click on the link https://www.editorialmanager.com/ath/. This will take you to the Atherosclerosis
Editorial Manager home page. The Author Information box to the right of the page provides relevant information, including a tutorial
on how to submit your manuscript.
Authors must select an appropriate Associate Editor from the list shown on the website, the expertise
terms for each Editor are shown to assist with this choice. Authors must suggest four potential reviewers for their paper, and to avoid
delay in processing your submission please ensure that email addresses given for reviewers are correct. The Editorial Board reserves
the right to decide whether or not the suggested reviewers are used. Please note the Associate Editors will not act as reviewers. Authors
may also indicate if a particular reviewer should not be approached.
Types of papers that can be submitted for consideration
by the Editorial Board include:
a) Basic Research Papers reporting results of original research or investigation using in
vitro, cell culture, or animal models. Basic Research Papers should not exceed 4000 words (including tables, references and legends
to figures).
b) Clinical Research Papers reporting results of original clinical research or investigation in human subjects.
Clinical Research Papers should not exceed 4000 words (including tables, references and legends to figures).
Basic and Clinical
Research papers must have no more than 5 figures and tables in total (e.g., 1 figure consisting of panels A and B, and 4 tables).
Authors are encouraged to include additional figures and tables as supplementary appendixes, and these will be considered for Web-only
publication.
Fast-track submission
For new findings of sufficient importance to justify accelerated review and publication,
a fast-track submission process for original articles is available. In the submission letter, authors should explicitly request this
option and provide credit card information (number, expiration date, and name as it appears on the card). If the editors agree that the
manuscript is worthy of fast-track publication, the fee of 600 Euros will be automatically charged to the credit card. If accepted for
fast-track submission, an article will be reviewed within 72 hours (otherwise, authors will be informed that the paper will be handled
within the normal peer-review process). If accepted, a fast-track submission will appear in the first available issue of the journal.
c) Review Articles and Mini-Reviews, usually by invitation. Mini-Reviews should normally consist of current short reviews
of topical information. Word limit: 3500 and 25 references and up to 3 tables and figures.
Full reviews may
contain up to 6 tables and figures and authors are encouraged to include a "mechanism/overview" figure. Word limit 5000
and 60 references. Exceptions to these limits should be discussed with the Reviews Editor before submission.
All Reviews
should be submitted for handling to the Reviews Editor, E.J. Schaefer.
d) Rapid Communications. These papers should provide
a brief but complete account of important new observations which merit urgent publication. The papers should be less than 5 printed
pages (8-10 double-spaced typed pages) including figures and tables and should be concisely but adequately referenced. Authors should
state in a covering e-mail why the paper merits urgent publication. Papers requiring revision will not be considered as Rapid Communications.
The Editor-in-Chief will normally reach a decision on these papers within one month.
e) Hypotheses and Viewpoints of up
to 1500 words are published occasionally. These contributions are subject to the normal editorial procedure. These should be submitted
to the Editor-in-Chief.
f) Letters to the Editor are welcomed. If the letter is a commentary relating to published work
in the journal, the other Author(s) will have the opportunity to reply in the same issue of the journal. Letters should not exceed 1200
words. These should be submitted to the Editor-in-Chief. Letters to the Editor that contain unpublished data or that are timely will
receive a higher priority.
g) Announcements of meetings, workshops, courses etc. are welcomed, subject to available space.
Correspondence
Correspondence can be sent to the Editor-in-Chief:
Professor Steve Humphries
Cardiovascular Genetics
University College London
Medical School, Rayne Institute
5 University Street
London WC1 E6JJ
UK
Fax: +44 20 7679
6212
E-mail: rmhasma@ucl.ac.uk
To ensure fast and efficient correspondence, all Authors must provide
recent e-mail addresses. Authors must submit the names, addresses, email addresses and phone/fax numbers of four potential reviewers.
Manuscripts
Original articles should report original research not previously published or being considered for publication
elsewhere. Please note, suspected cases of plagiarism or manipulation of data will be dealt with in consultation with the communicating
author and the relevant authorities (please see below).
Manuscripts should be written in the English language (using either American
or British spelling).
The number of words per manuscript should not exceed 4000 (including tables, references and legends to figures).
As a rule, research papers should be divided into sections, headed by a caption (e.g. Abstract, Introduction, Materials, Methods, Experimental
Results, Discussion, etc.).
Please include a short paragraph of conclusions (at the end of the text), indicating the relevance of
the study with regard to the basics and/or clinical aspect of atherosclerosis.
A statement concerning the source of funding, conflicts
of interests and disclosures of financial support is highly recommended.
Abstracts A structured abstract (objective,
methods, results and conclusion) of 50-250 words must be included.
Keywords
A keyword summary must be provided; normally
3-7 items should be included. Authors are encouraged to choose their own keywords but, if in grave doubt which items to select, Medical
Subject Headings (issued with the January Index Medicus, 1969) may be used as a guideline.
Illustrations
Figures should ideally be submitted in high-resolution TIF format, or alternatively in GIF, JPEG/JPG, or EPS format. The figures should
be placed in separate files, named purely with the figure numbers (e.g. "Figure1.tif"). Legends for figures should be typed
separately. The cost of colour figures will be paid by the Author.
Colour illustrations online
Please make sure that
artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. Polaroid colour prints are
not suitable.
If, together with your accepted article, you submit usable colour figures then Elsevier will ensure, at no additional
charge, that these figures will appear in colour on the Web (e.g. ScienceDirect and other sites) regardless of whether or not these illustrations
are reproduced in colour in the printed version. For colour reproduction in print, you will receive information regarding the costs from
Elsevier after receipt of your accepted article. Please indicate your preference for colour in print or on the Web only. For further
information on the preparation of electronic artwork, please see http://authors.elsevier.com/artwork. Please note: Because
of technical complications which can arise by converting colour figures to "grey scale" (for the printed version should you not opt for
colour in print) please submit in addition usable black and white versions of all the colour illustrations.
Tables
Tables
with titles and legends must be typed on separate pages and with double spacing. Authors must list on the title page or in the covering
e-mail, the number of figures and/or tables to be found in the paper.
References
References must be given at the
end of the paper, numbered in the order in which they occur in the text and quoted in the text at appropriate places. The number of references
must not exceed 30 (except for Reviews).
They should be arranged as follows: Authors (second name and initial of first name(s), e.g.
Mailhac A, Badimon JJ), title of article (upper case only on first word or proper nouns/names), title of journal (standard abbreviation
if possible), year of publication, volume number of journal and page range (e.g. 1432-6).
References to books should include: Author's
and/or Editor's name(s), title of book, place of publication, publisher, year, page numbers (if necessary). This journal should be cited
as Atherosclerosis.
DNA sequences and GenBank accession numbers
For each and every gene accession number cited
in an article, Authors must type the accession number in bold, underlined text. Letters in the accession number must always
be capitalised.
Example: (GenBank accession nos. AI631510, AI631511, AI632198, and BF223228),
a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession
no. AA361117).
For all gene variants the rs number must be provided. Current standard nomenclature for designation
of DNA sequence variants must be adhered to: http://www.hgvs.org.
In order to allow for the work to be reproduced by
others, where not previously published, authors are encouraged to provide as supplementary material for web-publication only, the primers
and PCR conditions for all variants genotyped in the manuscript.
Preparation of supplementary data
Elsevier now accepts
electronic supplementary material (e-components) to support and enhance your scientific research. Supplementary files offer the Author
additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets,
sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier
Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is
directly usable, please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic
format together with the article and supply a concise and descriptive caption for each file.
For more detailed instructions please visit
our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Language Editing
International
Science Editing and Asia Science Editing can provide English language and copyediting services to authors who want to publish in scientific,
technical and medical journals and need assistance before they submit their article or, before it is accepted for publication. Authors
can contact these services directly: International Science Editing (http://www.internationalscienceediting.com) and Asia
Science Editing (http://www.asiascienceediting.com) or, for more information about language editing services, please contact
authorsupport@elsevier.com who will be happy to deal with any questions.
Please note Elsevier neither endorses nor takes responsibility
for any products, goods or services offered by outside vendors through our services or in any advertising. For more information please
refer to our terms and conditions:
http://www.elsevier.com/locate/languagepolishing.
Reprints
PDF offprints
are provided free of charge. No reprints are provided free of charge. Reprints (50 copies minimum) can be ordered at quoted prices on
order forms sent out together with the proofs.
General
Submission of an article implies that the work described has not
been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under
consideration for publication elsewhere, that its publication is approved by all Authors and tacitly or explicitly by the responsible
authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or
in any other language, without the written consent of the Publisher. Parallel submissions will not be tolerated.
Atherosclerosis
will not tolerate plagiarism in submitted manuscripts. Passages quoted or closely paraphrased from other authors (or from the submitting
author's own published work) must be identified as quotations or paraphrases and sources quoted or paraphrased material must be acknowledged.
Use of unacknowledged sources will be construed as plagiarism. If any manuscript is found to contain plagiarised material the review
process will be halted immediately, and the University or Institute of the corresponding Author will be informed. Atherosclerosis
will not tolerate manipulation or enhancement of data. Authors will be asked to provide further evidence for the validity of data, and
the University or Institute of the corresponding Author will be informed if such evidence is not forthcoming.
Upon acceptance of
an article, Authors will be asked to transfer copyright (for more information on copyright see http://authors.elsevier.com).
This transfer will ensure the widest possible dissemination of information. If excerpts from other copyrighted works are included,
the Author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted
forms for use by Authors in these cases: contact Elsevier's Rights Department, Philadelphia, PA, USA. Tel: (+1) 215 238 7869; fax: (+1)
215 238 2239; e-mail: healthpermissions@elsevier.com. Requests may also be completed online via the Elsevier homepage:
http://www.elsevier.com/locate/permissions.
Elsevier will do everything possible to get your article corrected and published
as quickly and accurately as possible. Therefore, it is important to ensure that all of your corrections are sent back to us in one
communication. Subsequent corrections will not be possible, so please ensure your first sending is complete.
Funding body
agreements and policies Elsevier has established agreements and developed policies to allow authors whose articles appear in
journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant
awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies
